Benchmark dose and the three Rs. Part II. Consequences for study design and animal use

SlobW2025-03-242025-03-2420142500033110.3109/10408444.2014.925424https://rivm.openrepository.com/handle/10029/647670Benchmark dose and the three Rs. Part II. Consequences for study design and animal useArticleCrit Rev Toxicol 2014; 44(7):568-802025-03-24